Frisco Medical Center, L.L.P., a Texas Limited Liability Partnership, and Texas Regional Medical Center, L.L.C., a Texas Limited Liability Company v. Paula Chestnut and Wendy Bolen, on Behalf of Themselves and All Others Similarly Situated

Court of Appeals of Texas·Decided November 7, 2022·No. 05-22-00058-CV·Published

Opinion

Affirmed in part; Reversed in part and Remanded and Opinion Filed November 7, 2022

In the

Court of Appeals

Fifth District of Texas at Dallas No. 05-22-00058-CV

FRISCO MEDICAL CENTER, L.L.P. AND TEXAS REGIONAL MEDICAL CENTER, L.L.C., Appellants V.

PAULA CHESTNUT AND WENDY BOLEN, ON BEHALF OF THEMSELVES AND ALL OTHERS SIMILARLY SITUATED, Appellees

On Appeal from the 191st Judicial District Court Dallas County, Texas

Trial Court Cause No. DC-19-07283

MEMORANDUM OPINION

Before Justices Molberg, Partida-Kipness, and Carlyle Opinion by Justice Carlyle Frisco Medical Center, L.L.P. and Texas Regional Medical Center, L.L.C. (the

Hospitals) appeal the trial court’s order granting appellees Paula Chestnut and Wendy Bolen’s motion for class certification in a lawsuit regarding emergency medical care fees. The Hospitals contend the trial court erred because (1) Texas Rule of Civil Procedure 42’s class certification requirements were not met; (2) the class definition is improper; and (3) the order’s trial plan is insufficient. We reverse the

trial court’s order in part, affirm the order in part, and remand this case to the trial court for further proceedings. Background Appellees filed this class action lawsuit against the Hospitals in May 2019, complaining of the Hospitals’ “unfair, false, misleading and deceptive practice of charging emergency care patients, seen at one of Defendants’ hospital emergency room facilities, an ‘Evaluation and Management Services Fee’ (hereinafter ‘E&M Fee’) without providing notification of Defendants’ intention to charge such a Fee for the patient’s emergency room visit.” In their live petition, appellees contended (1) “none of Defendants’ Contracts described, mentioned, or informed emergency care patients of the hospital’s intention to charge an E&M Fee for being seen and treated in the hospital’s emergency room facilities”; (2) “neither the E&M Fee nor the intention to add an E&M Fee to the Total Charges billed to the patient’s account is or was disclosed on any signage posted in or around the emergency room facilities, or disclosed verbally during the patient’s registration process”; (3) “[d]espite the lack of disclosure, at all relevant times Defendants had a practice of charging emergency department patients a hidden and undisclosed E&M Fee set at one of five levels generally related to the seriousness and complexity of the patient’s condition, with such level being determined after treatment had been furnished, based on a secret formula or algorithm known only to Defendants”; (4) “a reasonable consumer would deem advance knowledge that he or she would be charged a substantial E&M

Fee to be an important factor in determining whether or not to remain for treatment at Defendants’ facilities or seek less costly treatment elsewhere”; and (5) “emergency care patients have an absolute right to be informed about a substantial E&M Fee prior to receiving treatment that will trigger such charge.”

The petition also stated:

This complaint applies to patients who received treatment and services at one of Defendants’ hospital emergency care facilities on or after July 10, 2015, who were assessed an Evaluation and Management Services Fee for their emergency room visit designated with a CPT Code of 99281, 99282, 99283, 99284, or 99285, and who made payments for their visit and/or have a remaining account balance which has not been formally discharged or waived. By this complaint, Plaintiffs seek declaratory relief, injunctive relief, and restitution, on the basis that these E&M Fees were never properly disclosed in advance of treatment or agreed to. The relief requested is based on the fact that Defendants’ billing practices with respect to the undisclosed E&M Fees were and continue to be unfair, unreasonable, unconscionable and/or violative of the Texas Deceptive Trade Practices–Consumer Protection Act, Tex. Bus. & Com. Code § 17.41 et seq. (“DTPA”), as well as Texas’ common law.

The petition asserted two causes of action: “declaratory judgment” and “request for relief under DTPA.”

In their declaratory judgment cause of action, appellees stated:

Plaintiffs and the members of the Class . . . contend that under Defendants’ Contracts they should not have been required to pay for undisclosed E&M Fees. . . . To resolve the ongoing disputes over the propriety of Defendants’ E&M Fees being charged under the circumstances described herein, Plaintiffs and the members of the Class are entitled to a determination as to whether patients had a “right to know” and/or Defendants had a “duty to disclose” their E&M Fees in advance of such E&M Fees being incurred, and are further entitled to a declaration and appropriate injunctive relief with regard to a patient’s

legal rights and duties and the construction of Defendants’ form Contracts. Specifically, Plaintiffs and the members of the Class are entitled to a declaration that Defendants’ practice of charging a substantial undisclosed E&M Fee in addition to the charges for the specific services and treatments provided was not authorized by Defendants’ form Contracts, was violative of Texas common law, and was violative of the DTPA.

That cause of action also asserted (1) plaintiffs and class members are entitled to “equitable relief, including restitution,” and (2) the portions of the amounts plaintiffs and class members have paid that are attributable to the E&M Fees, and the cancellation of those portions of outstanding account balances that are attributable to the E&M Fees, “can be readily determined from Defendants’ existing records without the need for individual trials or hearings.” The petition asked the trial court to “issue a declaratory judgment declaring one or more of the following”:

(a) that Defendants’ billing practices with respect to E&M Fees as they relate to Plaintiffs and the Class are unconscionable under Texas common law;

(b) that Defendants’ billing practices with respect to E&M Fees as they relate to Plaintiffs and the Class are an unconscionable action or course of action as defined by Tex. Bus. & Com. Code §17.45(5), a provision of the DTPA;

(c) that the form Contracts used in Defendants’ emergency room facilities during the class period do not describe, mention, or authorize the undisclosed E&M Fees complained of herein;

(d) that Plaintiffs and members of the Class are not liable to Defendants for the E&M charges and are entitled to a refund of those portions of patient payments attributable to the E&M Fees; and

(e) that Defendants’ billing practices as they relate to Plaintiffs and the Class are deceptive trade practices as defined in the DTPA and, more particularly, by Tex. Bus. & Com. Code §§ 17.46 and 17.50.

In their DTPA cause of action, appellees asserted the Hospitals “have committed one or more ‘false, misleading, or deceptive acts or practices’ and/or unconscionable trade practices” that “constitute one or more violations of . . . the DTPA: Tex. Bus. & Com. Code § 17.46(b), subparts (12) and (24), and Tex. Bus. & Com. Code § 17.50(a), subparts (1) and (3).” Appellees sought an order enjoining the Hospitals from:

(a) seeking collection of the undisclosed E&M Fees from Plaintiffs and the members of the Class who have existing outstanding account balances;

(b) representing that the Contracts authorize Defendants to charge undisclosed E&M Fees when they do not; and

(c) continuing to charge E&M Fees without informing emergency room patients of such charges in advance of their being incurred.

Appellees’ DTPA cause of action also stated they “further seek restitution of payments made by class members attributable to the E&M Fees charged for their emergency room visit.”

Free access — add to your briefcase to read the full text and ask questions with AI

Frisco Medical Center, L.L.P., a Texas Limited Liability Partnership, and Texas Regional Medical Center, L.L.C., a Texas Limited Liability Company v. Paula Chestnut and Wendy Bolen, on Behalf of Themselves and All Others Similarly Situated, (Tex. Ct. App. 2022).

Frisco Medical Center, L.L.P., a Texas Limited Liability Partnership, and Texas Regional Medical Center, L.L.C., a Texas Limited Liability Company v. Paula Chestnut and Wendy Bolen, on Behalf of Themselves and All Others Similarly Situated (Frisco Medical Center, L.L.P., a Texas Limited Liability Partnership, and Texas Regional Medical Center, L.L.C., a Texas Limited Liability Company v. Paula Chestnut and Wendy Bolen, on Behalf of Themselves and All Others Similarly Situated) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Wal-Mart Stores, Inc. v. Dukes
131 S. Ct. 2541 (Supreme Court, 2011)
Compaq Computer Corp. v. Lapray
135 S.W.3d 657 (Texas Supreme Court, 2004)
Citizens Insurance Co. of America v. Daccach
217 S.W.3d 430 (Texas Supreme Court, 2007)
Bowden v. Phillips Petroleum Co.
247 S.W.3d 690 (Texas Supreme Court, 2008)
Henry Schein, Inc. v. Stromboe
102 S.W.3d 675 (Texas Supreme Court, 2002)
Southwestern Refining Co., Inc. v. Bernal
22 S.W.3d 425 (Texas Supreme Court, 2000)
Bailey v. Kemper Casualty Insurance Co.
83 S.W.3d 840 (Court of Appeals of Texas, 2002)
Intercontinental Hotels Corp. v. Girards
217 S.W.3d 736 (Court of Appeals of Texas, 2007)
Union Pacific Resources Group, Inc. v. Hankins
111 S.W.3d 69 (Texas Supreme Court, 2003)
Walker v. Packer
827 S.W.2d 833 (Texas Supreme Court, 1992)
Riemer v. State
452 S.W.3d 491 (Court of Appeals of Texas, 2014)